Parion Sciences

May 26, 2015November 5, 2015

Parion Sciences Receives 2015 Life Sciences Award

Cystic Fibrosis, News

Parion Sciences, a firm committed to developing new treatments to address pulmonary and ocular diseases, recently announced that it was named the Best Late Stage Product Development Company by the Triangle Business Journal and accounting firm BDO. ... Read more

November 4, 2014November 11, 2015

$15.6 Million Investment In Parion’s Pulmonary Research Program Might Have Huge Impact In Pulmonary Diseases

COPD, News

A five-year, $15.6 million award was recently announced for supporting continued research into mucolytic agents developed by Parion Sciences and to enable Investigational New Drug (IND) applications for these molecules. The funding ... Read more

October 17, 2014November 11, 2015

Universities Receive NIH Grants to Study Parion Sciences Products for Pulmonary Diseases

COPD, News

Emerging biopharmaceutical company, Parion Sciences, announced earlier this week that several universities have just been awarded a 5-year grant worth an estimated $15.6 million from the National Institutes of health (NIH). ... Read more